Currently we test and support the following browsers:
Please note that this is not intended to be an exhaustive list of browsers that support web standards, nor a test of browser compliance, nor a side-by-side comparison of various manufacturers’ browsers.
St. Jude scientists identify key molecular events in pediatric adrenocortical tumors. The findings could help clinicians identify most malignant subtypes and lead to better treatment.
St. Jude Children’s Research Hospital physician receives the Paul P. Carbone Award in International Oncology from the International Network for Cancer Treatment and Research for his efforts to improve childhood cancer survival rates across the globe.
One gray, winter day a cyclone picked up tiny Ellen Taylor and plopped her into an alien land. How could she muster the wisdom, the courage and the heart to travel the difficult road ahead?
Scientists at St. Jude Children’s Research Hospital who represent the interdisciplinary team studying acute lymphoblastic leukemia (ALL) have been recognized by the American Association for Cancer Research (AACR) with the AACR Team Science Award.
The mission of St. Jude Children’s Research Hospital extends far beyond the borders of the United States. An interactive Web site known as Oncopedia helps health care providers in the world’s most remote regions access St. Jude knowledge and research with the click of a computer mouse.
A small hike in funding for pediatric cancer care could significantly boost survival rates in low- and middle-income nations, according to an international team lead by St. Jude.
St. Jude has significantly reduced the rate at which families in Recife, Brazil, abandon treatment for their children who have acute lymphoblastic leukemia, and has significantly increased the rate of event-free survival during a single decade.
A small pilot program in the People's Republic of China has saved the lives of children who would otherwise have died from acute lymphoblastic leukemia (ALL) because of their family's inability to pay for care.
A simple new test is inexpensive enough to use routinely in institutes with limited resources; it guides fine-tuning of follow-up therapy to save more children from harsh chemotherapy and fatal infections.
A review of long-term results of acute myeloid leukemia (AML) clinical trials at St. Jude suggests that the "one-size-fits-all" approach of the past 20 years should be replaced with therapies designed for specific subtypes of AML.
Partnerships between institutions from developed and underdeveloped countries could improve treatment of children with cancer even in areas of the world that have limited resources, according to St. Jude.
Cure4Kids.org has achieved a milestone reaching Cote d'Ivoire, the 100th country to join the program.
The city of Recife, Brazil, experienced a significant improvement in outcome among children treated for acute lymphoblastic leukemia (ALL) during the past decade, even though the community is resource-poor and most patient families are impoverished.
Why are children in southern Brazil more susceptible to a rare type of cancer than children in other parts of the world? St. Jude researchers and clinicians spend more than a decade unraveling the mystery.